[Autoantibodies and Leishmania infection]

Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

ESMO open·2026

New prognostic and predictive scoring systems for colorectal cancer liver metastases.

ESMO open·2026

Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations.

ESMO gastrointestinal oncology·2026

Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trial.

ESMO gastrointestinal oncology·2026

Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients.

ESMO gastrointestinal oncology·2026

Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approaches.

ESMO open·2025

Optimising the duration of antimicrobial treatment in the era of Antimicrobial Stewardship Programs.

Medicina clinica·2026

Reduced serum IL-6 as a potential peripheral marker of amnestic mild cognitive impairment: A pilot study.

Medicina clinica·2026

Foundations for the rational prescription of enteral medical nutrition therapy.

Medicina clinica·2026

Ambient AI scribe in pediatric outpatient visits: documentation burden, quality, and scale-up limits.

Medicina clinica·2026

Eating disorders.

Medicina clinica·2026

Tobacco-related and tobacco-attributable cancer mortality in Spain, 1999-2023: trends and gender inequalities.

Medicina clinica·2026

The why, what, who and when of B cell depletion in systemic lupus erythematosus: Biological rationale, patient stratification and evolving therapeutic modalities.

Rheumatology (Oxford, England)·2026

Immune checkpoint inhibitor-associated severe hyponatremia: evidence mapping of SIADH-like phenotypes and endocrine immune-related adverse events.

Endocrine connections·2026

Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

Giant cell arteritis during risankizumab therapy: a possible paradoxical reaction to IL-23 inhibition.

Immunological medicine·2026

Small Intestinal Extranodal Marginal Zone Lymphoma Mimicking Crohn's Disease.

ACG case reports journal·2026

A Pancreas Out of Place: Acute Interstitial Pancreatitis Caused by Pancreatic Herniation in a Type IV Paraesophageal Hernia.

ACG case reports journal·2026

Related Experiment Videos

[Autoantibodies and Leishmania infection]

Related Concept Videos

Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

New prognostic and predictive scoring systems for colorectal cancer liver metastases.

Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations.

Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trial.

Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients.

Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approaches.

Optimising the duration of antimicrobial treatment in the era of Antimicrobial Stewardship Programs.

Reduced serum IL-6 as a potential peripheral marker of amnestic mild cognitive impairment: A pilot study.

Foundations for the rational prescription of enteral medical nutrition therapy.

Ambient AI scribe in pediatric outpatient visits: documentation burden, quality, and scale-up limits.

Eating disorders.

Tobacco-related and tobacco-attributable cancer mortality in Spain, 1999-2023: trends and gender inequalities.

The why, what, who and when of B cell depletion in systemic lupus erythematosus: Biological rationale, patient stratification and evolving therapeutic modalities.

Immune checkpoint inhibitor-associated severe hyponatremia: evidence mapping of SIADH-like phenotypes and endocrine immune-related adverse events.

Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.

Giant cell arteritis during risankizumab therapy: a possible paradoxical reaction to IL-23 inhibition.

Small Intestinal Extranodal Marginal Zone Lymphoma Mimicking Crohn's Disease.

A Pancreas Out of Place: Acute Interstitial Pancreatitis Caused by Pancreatic Herniation in a Type IV Paraesophageal Hernia.

Related Experiment Videos

[Autoantibodies and Leishmania infection]

Related Concept Videos

Related Articles